Charts Suven Life Sciences Limited NSE India S.E.

Equities

Market Closed - NSE India S.E. Other stock markets 07:43:49 2024-05-03 am EDT			5-day change	1st Jan Change
113.8 ^INR	+0.84%		+2.06%	+40.87%

Apr. 15	Suven Life Sciences to Present Phase-2 Positive Results on Samelisant (SUVN-G3031) at American Academy of Neurology 2024 Annual Meeting, Denver, USA	CI
Feb. 06	Suven Life Sciences Announces Randomization of First Patient in Phase-2 POC Clinical Trial of Ropanicant (SUVN-911) for the Treatment of Moderate to Severe Major Depressive Disorder Study in USA	CI

ProRealTime Chart